Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial.
BACKGROUND: Data on therapeutic interventions following deliberate self harm (DSH) in patients with treatment-resistant depression (TRD) are very scant and there is no unanimous consensus on the best pharmacological option for these patients. There is some evidence that lithium treatment might be e...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2013
|
| _version_ | 1826301560627396608 |
|---|---|
| author | Cipriani, A Girlanda, F Agrimi, E Barichello, A Beneduce, R Bighelli, I Bisoffi, G Bisogno, A Bortolaso, P Boso, M Calandra, C Cascone, L Corbascio, C Parise, V Gardellin, F Gennaro, D Hanife, B Lintas, C Lorusso, M Luchetta, C Lucii, C Cernuto, F Tozzi, F Marsilio, A Maio, F Mattei, C Moretti, D Appino, MG Nosè, M Occhionero, G Papanti, D Pecile, D Purgato, M Prestia, D Restaino, F Sciarma, T Ruberto, A Strizzolo, S Tamborini, S Todarello, O Ziero, S Zotos, S Barbui, C |
| author_facet | Cipriani, A Girlanda, F Agrimi, E Barichello, A Beneduce, R Bighelli, I Bisoffi, G Bisogno, A Bortolaso, P Boso, M Calandra, C Cascone, L Corbascio, C Parise, V Gardellin, F Gennaro, D Hanife, B Lintas, C Lorusso, M Luchetta, C Lucii, C Cernuto, F Tozzi, F Marsilio, A Maio, F Mattei, C Moretti, D Appino, MG Nosè, M Occhionero, G Papanti, D Pecile, D Purgato, M Prestia, D Restaino, F Sciarma, T Ruberto, A Strizzolo, S Tamborini, S Todarello, O Ziero, S Zotos, S Barbui, C |
| author_sort | Cipriani, A |
| collection | OXFORD |
| description | BACKGROUND: Data on therapeutic interventions following deliberate self harm (DSH) in patients with treatment-resistant depression (TRD) are very scant and there is no unanimous consensus on the best pharmacological option for these patients. There is some evidence that lithium treatment might be effective in reducing the risk of completed suicide in adult patients with unipolar affective disorders, however no clear cut results have been found so far. The primary aim of the present study is to assess whether adding lithium to standard therapy is an effective treatment strategy to reduce the risk of suicidal behaviour in long term treatment of people with TRD and previous history of DSH. METHODS/DESIGN: We will carry out a randomised, parallel group, assessor-blinded superiority clinical trial. Adults with a diagnosis of major depression, an episode of DSH in the previous 12 months and inadequate response to at least two antidepressants given sequentially at an adequate dose for an adequate time for the current depressive episode will be allocated to add lithium to current therapy (intervention arm) or not (control arm). Following randomisation, treatment is to be taken daily for 1 year unless some clear reason to stop develops. Suicide completion and acts of DSH during the 12 months of follow-up will constitute the composite primary outcome. To preserve outcome assessor blindness, an independent adjudicating committee, blind to treatment allocation, will anonymously review all outcome events. DISCUSSION: The results of this study should indicate whether lithium treatment is associated with lower risk of completed suicide and DSH in adult patients with treatment resistant unipolar depression, who recently attempted suicide. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00927550. |
| first_indexed | 2024-03-07T05:34:15Z |
| format | Journal article |
| id | oxford-uuid:e357dfaf-d8dd-4127-9c83-455823c06300 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:34:15Z |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:e357dfaf-d8dd-4127-9c83-455823c063002022-03-27T10:08:30ZEffectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e357dfaf-d8dd-4127-9c83-455823c06300EnglishSymplectic Elements at OxfordBioMed Central2013Cipriani, AGirlanda, FAgrimi, EBarichello, ABeneduce, RBighelli, IBisoffi, GBisogno, ABortolaso, PBoso, MCalandra, CCascone, LCorbascio, CParise, VGardellin, FGennaro, DHanife, BLintas, CLorusso, MLuchetta, CLucii, CCernuto, FTozzi, FMarsilio, AMaio, FMattei, CMoretti, DAppino, MGNosè, MOcchionero, GPapanti, DPecile, DPurgato, MPrestia, DRestaino, FSciarma, TRuberto, AStrizzolo, STamborini, STodarello, OZiero, SZotos, SBarbui, C BACKGROUND: Data on therapeutic interventions following deliberate self harm (DSH) in patients with treatment-resistant depression (TRD) are very scant and there is no unanimous consensus on the best pharmacological option for these patients. There is some evidence that lithium treatment might be effective in reducing the risk of completed suicide in adult patients with unipolar affective disorders, however no clear cut results have been found so far. The primary aim of the present study is to assess whether adding lithium to standard therapy is an effective treatment strategy to reduce the risk of suicidal behaviour in long term treatment of people with TRD and previous history of DSH. METHODS/DESIGN: We will carry out a randomised, parallel group, assessor-blinded superiority clinical trial. Adults with a diagnosis of major depression, an episode of DSH in the previous 12 months and inadequate response to at least two antidepressants given sequentially at an adequate dose for an adequate time for the current depressive episode will be allocated to add lithium to current therapy (intervention arm) or not (control arm). Following randomisation, treatment is to be taken daily for 1 year unless some clear reason to stop develops. Suicide completion and acts of DSH during the 12 months of follow-up will constitute the composite primary outcome. To preserve outcome assessor blindness, an independent adjudicating committee, blind to treatment allocation, will anonymously review all outcome events. DISCUSSION: The results of this study should indicate whether lithium treatment is associated with lower risk of completed suicide and DSH in adult patients with treatment resistant unipolar depression, who recently attempted suicide. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00927550. |
| spellingShingle | Cipriani, A Girlanda, F Agrimi, E Barichello, A Beneduce, R Bighelli, I Bisoffi, G Bisogno, A Bortolaso, P Boso, M Calandra, C Cascone, L Corbascio, C Parise, V Gardellin, F Gennaro, D Hanife, B Lintas, C Lorusso, M Luchetta, C Lucii, C Cernuto, F Tozzi, F Marsilio, A Maio, F Mattei, C Moretti, D Appino, MG Nosè, M Occhionero, G Papanti, D Pecile, D Purgato, M Prestia, D Restaino, F Sciarma, T Ruberto, A Strizzolo, S Tamborini, S Todarello, O Ziero, S Zotos, S Barbui, C Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial. |
| title | Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial. |
| title_full | Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial. |
| title_fullStr | Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial. |
| title_full_unstemmed | Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial. |
| title_short | Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial. |
| title_sort | effectiveness of lithium in subjects with treatment resistant depression and suicide risk a protocol for a randomised independent pragmatic multicentre parallel group superiority clinical trial |
| work_keys_str_mv | AT cipriania effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT girlandaf effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT agrimie effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT barichelloa effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT beneducer effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT bighellii effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT bisoffig effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT bisognoa effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT bortolasop effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT bosom effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT calandrac effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT casconel effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT corbascioc effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT parisev effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT gardellinf effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT gennarod effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT hanifeb effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT lintasc effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT lorussom effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT luchettac effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT luciic effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT cernutof effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT tozzif effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT marsilioa effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT maiof effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT matteic effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT morettid effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT appinomg effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT nosem effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT occhionerog effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT papantid effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT peciled effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT purgatom effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT prestiad effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT restainof effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT sciarmat effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT rubertoa effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT strizzolos effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT tamborinis effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT todarelloo effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT zieros effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT zotoss effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial AT barbuic effectivenessoflithiuminsubjectswithtreatmentresistantdepressionandsuicideriskaprotocolforarandomisedindependentpragmaticmulticentreparallelgroupsuperiorityclinicaltrial |